On February 4, 2021, Schenkel, Laurie B.; Vasbinder, Melissa Marie; Kuntz, Kevin Wayne; Perl, Nicholas Robert; Downing, Jennifer published a patent.Product Details of 1096481-48-9 The title of the patent was Preparation of pyrazolopyrimidine carboxamides and related heterobicyclic amides as inhibitors of CD38 useful in the treatment of cancer. And the patent contained the following:
The invention relates to preparation of pyrazolopyrimidine carboxamides and related heterobicyclic amides(I) which are inhibitors of CD38 and are useful in the treatment of cancer. Compounds I wherein V is N or CRv; Rv is H, halo, or C1-4 alkyl; W is N or CRw; Rw is H, halo, or C1-4 alkyl;; Ring A is a 5-membered heteroaryl group having 1, 2 or 3 ring-forming heteroatoms selected from N, O, and S; L is a C1-4 alkylene linker; n is 0 or 1; Q is H, C1-10 alkyl, C2-10 alkenyl, C2-10 alkynyl, etc.; etc…, are claimed. The example compound II was prepared via 3-steps synthesis using imidazole as starting material (procedure given). Compounds I were evaluated for their biol. activity (data given). Compounds I can be useful in treatment of cancers. The experimental process involved the reaction of Methyl 2-amino-5-iodo-3-methylbenzoate(cas: 1096481-48-9).Product Details of 1096481-48-9
The Article related to pyrazolopyrimidine carboxamide preparation cd38 inhibitor antitumor cancer, heterobicyclic amide preparation cd38 inhibitor antitumor cancer, Heterocyclic Compounds (More Than One Hetero Atom): Pyrimidines and Quinazolines and other aspects.Product Details of 1096481-48-9
Referemce:
Iodide – Wikipedia,
Iodide – an overview | ScienceDirect Topics – ScienceDirect.com